TY - JOUR
T1 - Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus
AU - Wilson, Tracey E.
AU - Barrón, Yolanda
AU - Cohen, Mardge
AU - Richardson, Jean
AU - Greenblatt, Ruth
AU - Sacks, Henry S.
AU - Young, Mary
N1 - Funding Information:
Financial support: National Institute of Allergy and Infectious Diseases (NIAID) grant R01-AI-31834 and CONRAD Program subproject agreement CSA-94-134. The Women’s Interagency HIV Study is funded by the NIAID, with supplemental funding from the National Cancer Institute, the National Institute of Child Health and Human Development, the National Institute on Drug Abuse, the National Institute of Dental and Craniofacial Research, the Agency for Health Care Policy and Research, the National Center for Research Resources, and the Centers for Disease Control and Prevention (grant numbers U01-AI-35004, U01-AI-31834, U01-AI-34994, U01-AI-34989, U01-HD-32632 [NICHD], U01-AI-34993, U01-AI-42590, M01-RR00079, and M01-RR00083, respectively).
PY - 2002/2/15
Y1 - 2002/2/15
N2 - To delineate the relationship between adherence to human immunodeficiency virus (HIV) therapy and sexual behavior among HIV type 1-infected women in the United States, data were collected from October 1998 through March 1999 from 766 HIV-positive women on adherence to therapy, risk behavior, and disease markers. Adherence rates of ≥95% were reported by 66% of the patients. In multivariate analyses, patients with lower rates of adherence tended to be younger (odds ratio [OR], 1.69), to be active drug users (OR, 2.27), to have detectable virus load levels (OR, 2.00), and to have a lower quality of life (OR, 1.20). Among sexually active women, lower adherence rates were associated with an increased risk for inconsistent condom use (adjusted OR, 2.17). Although counseling regarding sexual behavior and adherence to treatment regimens are often addressed separately, our data highlight the importance of discussing these factors in relation to one another, particularly with regard to patients experiencing virologic failure.
AB - To delineate the relationship between adherence to human immunodeficiency virus (HIV) therapy and sexual behavior among HIV type 1-infected women in the United States, data were collected from October 1998 through March 1999 from 766 HIV-positive women on adherence to therapy, risk behavior, and disease markers. Adherence rates of ≥95% were reported by 66% of the patients. In multivariate analyses, patients with lower rates of adherence tended to be younger (odds ratio [OR], 1.69), to be active drug users (OR, 2.27), to have detectable virus load levels (OR, 2.00), and to have a lower quality of life (OR, 1.20). Among sexually active women, lower adherence rates were associated with an increased risk for inconsistent condom use (adjusted OR, 2.17). Although counseling regarding sexual behavior and adherence to treatment regimens are often addressed separately, our data highlight the importance of discussing these factors in relation to one another, particularly with regard to patients experiencing virologic failure.
UR - http://www.scopus.com/inward/record.url?scp=0037082966&partnerID=8YFLogxK
U2 - 10.1086/338397
DO - 10.1086/338397
M3 - Article
C2 - 11797182
AN - SCOPUS:0037082966
SN - 1058-4838
VL - 34
SP - 529
EP - 534
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 4
ER -